These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16110481

  • 1. p53 and the malignant progression of Barrett's esophagus.
    Merola E, Claudio PP, Giordano A.
    J Cell Physiol; 2006 Mar; 206(3):574-7. PubMed ID: 16110481
    [Abstract] [Full Text] [Related]

  • 2. Barrett's esophagus.
    Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC.
    J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
    [Abstract] [Full Text] [Related]

  • 3. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
    Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ.
    J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
    [Abstract] [Full Text] [Related]

  • 4. [Gastroesophageal reflux disease and malignancy].
    Richert Z, Robaszkiewicz M.
    Rev Prat; 2008 Sep 15; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [Abstract] [Full Text] [Related]

  • 5. The molecular biology of esophageal adenocarcinoma.
    Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN.
    J Surg Oncol; 2005 Dec 01; 92(3):169-90. PubMed ID: 16299787
    [Abstract] [Full Text] [Related]

  • 6. Barrett's esophagus: can biomarkers predict progression to malignancy?
    Tischoff I, Tannapfel A.
    Expert Rev Gastroenterol Hepatol; 2008 Oct 01; 2(5):653-63. PubMed ID: 19072343
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L, Pregun I, Tulassay Z.
    Dig Dis; 2009 Oct 01; 27(1):24-30. PubMed ID: 19439957
    [Abstract] [Full Text] [Related]

  • 8. [Barrett's metaplasia].
    Mach T, Cibor D.
    Folia Med Cracov; 1999 Oct 01; 40(3-4):5-16. PubMed ID: 10909470
    [Abstract] [Full Text] [Related]

  • 9. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E.
    Pol Merkur Lekarski; 2009 May 01; 26(155):385-9. PubMed ID: 19606680
    [Abstract] [Full Text] [Related]

  • 10. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
    Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P.
    Surgery; 2005 Oct 01; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
    [Abstract] [Full Text] [Related]

  • 11. Molecular markers and genetics in cancer development.
    Hormi-Carver K, Souza RF.
    Surg Oncol Clin N Am; 2009 Jul 01; 18(3):453-67. PubMed ID: 19500736
    [Abstract] [Full Text] [Related]

  • 12. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA, van Lanschot JJ, Dinjens WN, Wijnhoven BP.
    Recent Results Cancer Res; 2010 Jul 01; 182():39-63. PubMed ID: 20676870
    [Abstract] [Full Text] [Related]

  • 13. Chromosomal instability in Barrett's esophagus is related to telomere shortening.
    Finley JC, Reid BJ, Odze RD, Sanchez CA, Galipeau P, Li X, Self SG, Gollahon KA, Blount PL, Rabinovitch PS.
    Cancer Epidemiol Biomarkers Prev; 2006 Aug 01; 15(8):1451-7. PubMed ID: 16896031
    [Abstract] [Full Text] [Related]

  • 14. Clinical use of p53 in Barrett's esophagus.
    Keswani RN, Noffsinger A, Waxman I, Bissonnette M.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 01; 15(7):1243-9. PubMed ID: 16835318
    [Abstract] [Full Text] [Related]

  • 15. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.
    Am J Gastroenterol; 2009 Nov 01; 104(11):2673-80. PubMed ID: 19638963
    [Abstract] [Full Text] [Related]

  • 16. Multistage carcinogenesis in Barrett's esophagus.
    Maley CC.
    Cancer Lett; 2007 Jan 08; 245(1-2):22-32. PubMed ID: 16713672
    [Abstract] [Full Text] [Related]

  • 17. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF, Krishnan K, Spechler SJ.
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug 08; 295(2):G211-8. PubMed ID: 18556417
    [Abstract] [Full Text] [Related]

  • 18. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U, Malfertheiner P.
    Z Gastroenterol; 2007 Dec 08; 45(12):1264-72. PubMed ID: 18080229
    [Abstract] [Full Text] [Related]

  • 19. New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.
    Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D.
    J Surg Res; 2005 May 15; 125(2):189-212. PubMed ID: 15854673
    [Abstract] [Full Text] [Related]

  • 20. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
    Chung SM, Kao J, Hyjek E, Chen YT.
    Int J Oncol; 2007 Dec 15; 31(6):1351-5. PubMed ID: 17982662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.